glp 1 insurance companies scrambling to support need for GLP-1 drugs - The C.O.R.E. Group GLP-1 Coverage in Employer Plans

The oral formulation is the most significant differentiator: if an oral tablet can produce weight loss comparable to injectable CagriSema, it could fundamentally change how dual pathway obesity therapy is delivered

diarrhea 49% vs

Initial clinical findings suggest that GLP-1 receptor agonists could provide an effective therapeutic strategy in patients with AD and those at risk, however, there remains a lack of sufficient evidence in large clinical samples to draw any firm conclusions

Hunger JM, Major B, Blodorn A, Miller CT

Alcohol urges questionnaire Craving was assessed using the Alcohol Urge Questionnaire (AUQ) 80

Best for pre-diabetes and mild overweight (BMI 27-32), not severe obesity